Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019429385> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- W2019429385 abstract "Background In 2006 Novo Nordisk decided to invest in building a pipeline within inflammatory disease management. To support this strategy the cell culture units had to establish technology for expression and production of monoclonal antibodies in CHO cells. A number of technology providers at that time offered proven platform processes for this purpose. It was decided to in-license one of these technology platforms, the one developed at Lonza Biologics, and focus research resources on product innovation rather than development of an in-house production system. The platform has now been fully implemented and the work flow optimised and standardised." @default.
- W2019429385 created "2016-06-24" @default.
- W2019429385 creator A5015491673 @default.
- W2019429385 creator A5083988136 @default.
- W2019429385 date "2011-11-22" @default.
- W2019429385 modified "2023-09-25" @default.
- W2019429385 title "Platform process for production of monoclonal antibodies for research purposes – improvement option" @default.
- W2019429385 doi "https://doi.org/10.1186/1753-6561-5-s8-p44" @default.
- W2019429385 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3285018" @default.
- W2019429385 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22373264" @default.
- W2019429385 hasPublicationYear "2011" @default.
- W2019429385 type Work @default.
- W2019429385 sameAs 2019429385 @default.
- W2019429385 citedByCount "0" @default.
- W2019429385 crossrefType "journal-article" @default.
- W2019429385 hasAuthorship W2019429385A5015491673 @default.
- W2019429385 hasAuthorship W2019429385A5083988136 @default.
- W2019429385 hasBestOaLocation W20194293851 @default.
- W2019429385 hasConcept C111919701 @default.
- W2019429385 hasConcept C139719470 @default.
- W2019429385 hasConcept C159654299 @default.
- W2019429385 hasConcept C162324750 @default.
- W2019429385 hasConcept C203014093 @default.
- W2019429385 hasConcept C2778348673 @default.
- W2019429385 hasConcept C41008148 @default.
- W2019429385 hasConcept C542903549 @default.
- W2019429385 hasConcept C71924100 @default.
- W2019429385 hasConcept C98045186 @default.
- W2019429385 hasConceptScore W2019429385C111919701 @default.
- W2019429385 hasConceptScore W2019429385C139719470 @default.
- W2019429385 hasConceptScore W2019429385C159654299 @default.
- W2019429385 hasConceptScore W2019429385C162324750 @default.
- W2019429385 hasConceptScore W2019429385C203014093 @default.
- W2019429385 hasConceptScore W2019429385C2778348673 @default.
- W2019429385 hasConceptScore W2019429385C41008148 @default.
- W2019429385 hasConceptScore W2019429385C542903549 @default.
- W2019429385 hasConceptScore W2019429385C71924100 @default.
- W2019429385 hasConceptScore W2019429385C98045186 @default.
- W2019429385 hasIssue "S8" @default.
- W2019429385 hasLocation W20194293851 @default.
- W2019429385 hasLocation W20194293852 @default.
- W2019429385 hasLocation W20194293853 @default.
- W2019429385 hasLocation W20194293854 @default.
- W2019429385 hasLocation W20194293855 @default.
- W2019429385 hasOpenAccess W2019429385 @default.
- W2019429385 hasPrimaryLocation W20194293851 @default.
- W2019429385 hasRelatedWork W1969822711 @default.
- W2019429385 hasRelatedWork W1978576473 @default.
- W2019429385 hasRelatedWork W1999686187 @default.
- W2019429385 hasRelatedWork W2019666956 @default.
- W2019429385 hasRelatedWork W2036403810 @default.
- W2019429385 hasRelatedWork W2049834980 @default.
- W2019429385 hasRelatedWork W2063428357 @default.
- W2019429385 hasRelatedWork W2073840950 @default.
- W2019429385 hasRelatedWork W2340284051 @default.
- W2019429385 hasRelatedWork W4293213287 @default.
- W2019429385 hasVolume "5" @default.
- W2019429385 isParatext "false" @default.
- W2019429385 isRetracted "false" @default.
- W2019429385 magId "2019429385" @default.
- W2019429385 workType "article" @default.